肺癌治療藥的全球市場規模:各疾病類型(非小細胞肺癌，小細胞肺癌)，各治療法，各銷售管道，各地區的預測(2022年～2028年)

全球肺癌治療藥的市場規模，預計2021年價值約264億4,484萬美元，在預測期間的2022年～2028年預計以13％以上的健全成長率擴大。

工業化伴隨的公害增加，研究開發費增加，肺癌罹患率的上升牽引肺癌治療藥市場。還有研究的發展和完善的醫療系統的開發，支援肺癌治療藥的全球市場整體成長的可能性高。

可是，肺癌治療藥的高成本，有可能妨礙2022年～2028年的預測期間的市場擴大。

本報告提供全球肺癌治療藥市場調查，市場概要，產業分析，COVID-19的風險評估，各疾病類型，各治療法，各銷售管道，各地區的分析，及競爭等資訊。

目錄

第1章 摘要整理

第2章 全球肺癌治療藥市場:定義和範圍

第3章 全球肺癌治療藥市場:市場動態

• 肺癌治療藥市場:影響分析(2020年～2028年)

第4章 全球肺癌治療藥市場:產業分析

• 波特的五力分析
• PEST分析
• 投資採用模式
• 分析師的推薦事項與結論
• 主要的投資機會
• 主要的成功策略

第5章 風險評估:COVID-19影響

• COVID-19對產業的整體影響的評估
• COVID-19前、後的市場方案

第6章 全球肺癌治療藥市場:各疾病類型

• 市場概述
• 成果 - 潛力分析
• 估計、預測(2018年～2028年)
• 子區隔分析
  • 非小細胞肺癌(NSCLC)
  • 小細胞肺癌(SCLC)

第7章 全球肺癌治療藥市場:各治療法

• 市場概述
• 成果 - 潛力分析
• 估計、預測(2018年～2028年)
• 子區隔分析
  • 標靶治療
  • 免疫療法
  • 化療

第8章 全球肺癌治療藥市場:各銷售管道

• 市場概述
• 成果 - 潛力分析
• 估計、預測(2018年～2028年)
• 子區隔分析
  • 院內藥局
  • 零售藥局
  • 線上藥局
  • 其他

第9章 全球肺癌治療藥市場:各地區分析

• 各地區市場的概述
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美
  • 巴西
  • 墨西哥
• 全球其他地區

第10章 競爭資訊

• 主要市場策略
• 企業簡介
  • Genentech, Inc.
  • Eli Lillly and Company
  • Celgene Corporation
  • AstraZeneca
  • Pfizer Inc.
  • Sanofi Pharma
  • Novartis AG
  • Merck Sharp and Dohme Corp.
  • Millennium Pharmaceuticals Inc.
  • Astellas Pharma`2

第11章 調查流程

Global Lung Cancer Therapeutics Market is valued at approximately USD 26444.84 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 13 % over the forecast period 2022-2028. Lung cancer therapeutics comprise all the therapies to cure it. It is a fatal lung tumour characterised by uncontrolled cell proliferation in the lung tissues. The most significant risk factor for lung cancer is cigarette smoking. Lung cancer can also be caused by prolonged exposure to cigarette smoke. The diagnosis of lung cancer is verified by a biopsy performed under bronchoscopy or CT guidance. As a result, lung cancer can be treated using chemotherapy, radiation, immunotherapy, surgery, and other methods. Rising pollution due to Industrialization, increasing funding for Research & Development, and rising prevalence of Lung Cancer have driven the Lung Cancer Therapeutics Market. For Instance: As per the reports of the American Cancer Society, there will be 236,740 lung and bronchus cancer diagnoses and 130,180 deaths in the United States in 2022. About 85 percent of those cases are predicted to be NSCLC. Also, rising advancements in Research and development of a well-structured healthcare system are most likely to boost the overall growth of the Global Lung Cancer Therapeutics Market. However, high cost of Lung Cancer Therapeutics can obstruct the market's expansion over the projection period of 2022-2028.

The key regions considered for the global Lung Cancer Therapeutics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising development of a well-structured healthcare system and presence of major key players is driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 20222028. The market is expected to grow during the projected period, due to rising prevalence of Lung Cancer.

Major market players included in this report are:

Genentech Inc.

Eli Lillly and Company

Celgene Corporation

AstraZeneca

Pfizer Inc.

Sanofi Pharma

Novartis AG

Merck Sharp and Dohme Corp.

Millennium Pharmaceuticals Inc.

Astellas Pharma`2

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the Therapy within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC))

By Therapy:

Targeted Therapy

Immunotherapy

Chemotherapy

By Sales Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Lung Cancer Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Lung Cancer Therapeutics Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Lung Cancer Therapeutics Market, by Disease Type, 2020-2028 (USD Million)
  • 1.2.3. Lung Cancer Therapeutics Market, by Therapy, 2020-2028 (USD Million)
  • 1.2.4. Lung Cancer Therapeutics Market, by Sales-Channel, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Lung Cancer Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Lung Cancer Therapeutics Market Dynamics

• 3.1. Lung Cancer Therapeutics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising pollution due to Industrialization
    • 3.1.1.2. Increasing funding for Research & Development
    • 3.1.1.3. Rising prevalence of Lung Cancer
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Lung Cancer Therapeutics
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising advancements in Research
    • 3.1.3.2. Development of a well-structured Healthcare system

Chapter 4. Global Lung Cancer Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Lung Cancer Therapeutics Market, by Disease Type

• 6.1. Market Snapshot
• 6.2. Global Lung Cancer Therapeutics Market by Disease Type, Performance - Potential Analysis
• 6.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Disease Type, 2018-2028 (USD Million)
• 6.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Non-Small Cell Lung Cancer (NSCLC)
  • 6.4.2. Small Cell Lung Cancer (SCLC)

Chapter 7. Global Lung Cancer Therapeutics Market, by Therapy

• 7.1. Market Snapshot
• 7.2. Global Lung Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
• 7.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2018-2028 (USD Million)
• 7.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Targeted Therapy
  • 7.4.2. Immunotherapy
  • 7.4.3. Chemotherapy

Chapter 8. Global Lung Cancer Therapeutics Market, by Sales Channel

• 8.1. Market Snapshot
• 8.2. Global Lung Cancer Therapeutics Market by Sales Channel, Performance - Potential Analysis
• 8.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Sales Channel 2018-2028 (USD Million)
• 8.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Retail Pharmacies
  • 8.4.3. Online Pharmacies
  • 8.4.4. Others

Chapter 9. Global Lung Cancer Therapeutics Market, Regional Analysis

• 9.1. Lung Cancer Therapeutics Market, Regional Market Snapshot
• 9.2. North America Lung Cancer Therapeutics Market
  • 9.2.1. U.S. Lung Cancer Therapeutics Market
    • 9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Therapy breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. Sales Channel breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Lung Cancer Therapeutics Market
• 9.3. Europe Lung Cancer Therapeutics Market Snapshot
  • 9.3.1. U.K. Lung Cancer Therapeutics Market
  • 9.3.2. Germany Lung Cancer Therapeutics Market
  • 9.3.3. France Lung Cancer Therapeutics Market
  • 9.3.4. Spain Lung Cancer Therapeutics Market
  • 9.3.5. Italy Lung Cancer Therapeutics Market
  • 9.3.6. Rest of Europe Lung Cancer Therapeutics Market
• 9.4. Asia-Pacific Lung Cancer Therapeutics Market Snapshot
  • 9.4.1. China Lung Cancer Therapeutics Market
  • 9.4.2. India Lung Cancer Therapeutics Market
  • 9.4.3. Japan Lung Cancer Therapeutics Market
  • 9.4.4. Australia Lung Cancer Therapeutics Market
  • 9.4.5. South Korea Lung Cancer Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Lung Cancer Therapeutics Market
• 9.5. Latin America Lung Cancer Therapeutics Market Snapshot
  • 9.5.1. Brazil Lung Cancer Therapeutics Market
  • 9.5.2. Mexico Lung Cancer Therapeutics Market
• 9.6. Rest of The World Lung Cancer Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Genentech, Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Eli Lillly and Company
  • 10.2.3. Celgene Corporation
  • 10.2.4. AstraZeneca
  • 10.2.5. Pfizer Inc.
  • 10.2.6. Sanofi Pharma
  • 10.2.7. Novartis AG
  • 10.2.8. Merck Sharp and Dohme Corp.
  • 10.2.9. Millennium Pharmaceuticals Inc.
  • 10.2.10. Astellas Pharma`2

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Lung Cancer Therapeutics Market, report scope
• TABLE 2. Global Lung Cancer Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Lung Cancer Therapeutics Market estimates & forecasts by Disease Type 2018-2028 (USD Million)
• TABLE 4. Global Lung Cancer Therapeutics Market estimates & forecasts by Therapy 2018-2028 (USD Million)
• TABLE 5. Global Lung Cancer Therapeutics Market estimates & forecasts by Sales Channel 2018-2028 (USD Million)
• TABLE 6. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Lung Cancer Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global Lung Cancer Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. U.S. Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. Canada Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 20. Canada Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. Canada Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. UK Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 23. UK Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. UK Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. Germany Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 26. Germany Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. Germany Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. RoE Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 29. RoE Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. RoE Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. China Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 32. China Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. China Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. India Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 35. India Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. India Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. Japan Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 38. Japan Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. Japan Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 41. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. RoAPAC Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. Brazil Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 44. Brazil Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Brazil Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Mexico Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 47. Mexico Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. Mexico Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. RoLA Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 50. RoLA Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. RoLA Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. Row Lung Cancer Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 53. Row Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. Row Lung Cancer Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global Lung Cancer Therapeutics Market
• TABLE 56. List of primary sources, used in the study of global Lung Cancer Therapeutics Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Lung Cancer Therapeutics Market, research methodology
• FIG 2. Global Lung Cancer Therapeutics Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Lung Cancer Therapeutics Market, key trends 2021
• FIG 5. Global Lung Cancer Therapeutics Market, growth prospects 2022-2028
• FIG 6. Global Lung Cancer Therapeutics Market, porters 5 force model
• FIG 7. Global Lung Cancer Therapeutics Market, pest analysis
• FIG 8. Global Lung Cancer Therapeutics Market, value chain analysis
• FIG 9. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Lung Cancer Therapeutics Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Lung Cancer Therapeutics Market, regional snapshot 2018 & 2028
• FIG 15. North America Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
• FIG 16. Europe Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
• FIG 17. Asia Pacific Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
• FIG 18. Latin America Lung Cancer Therapeutics Market 2018 & 2028 (USD Million)
• FIG 19. Global Lung Cancer Therapeutics Market, company market share analysis (2021)